References
- Committee GEGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease updated 2015 Available from: http://www.goldcopd.orgAccessed September 11, 2015
- WiseRAThe value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progressionAm J Med200611941116996894
- TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med20083591543155418836213
- TashkinDPCelliBRDecramerMLystigTLiuDKestenSEfficacy of tiotropium in COPD patients with FEV1 ≥60% participating in the UPLIFT® trialCOPD2012928929622432932
- DecramerMCelliBKestenSLystigTMehraSTashkinDPEffect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trialLancet20093741171117819716598
- BridevauxP-OGerbaseMWProbst-HenschNMSchindlerCGaspozJ-MRochatTLong-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPDThorax20086376877418505800
- SocietyATStandardization of spirometry, 1994 updateAm Respir Crit Care Med19951511071136
- MorrisJFSpirometry in the evaluation of pulmonary functionWest J Med1976125110118969495
- PerkinsSMTuWUnderhillMGZhouXHMurrayMDThe use of propensity scores in pharmacoepidemiologic researchPharmacoepidemiol Drug Saf200099310119025807
- RosenbaumPRRubinDBThe central role of the propensity score in observational studies for causal effectsBiometrika1983704155
- ChenZDunsonDBRandom effects selection in linear mixed modelsBiometrics20035976276914969453
- CerveriICorsicoAGGrossoAThe rapid FEV1 decline in chronic obstructive pulmonary disease is associated with predominant emphysema: a longitudinal studyCOPD201310556123272662
- WatzHPittaFRochesterCLAn official European Respiratory Society statement on physical activity in COPDEur Respir J2014441521153725359358
- IncorvaiaCRussoAForesiAEffects of pulmonary rehabilitation on lung function in chronic obstructive pulmonary disease: the FIRST studyEur J Phys Rehabil Med20145041942624691247
- LeidyNSextonCJonesPMeasuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diaryThorax201469544344924595666
- CelliBRPredictors of mortality in COPDRespir Med201010477377920417082
- HoeseinFAMde HoopBZanenPCT-quantified emphysema in male heavy smokers: association with lung function declineThorax20116678278721474499
- WashkoGRRate of decline in FEV1: is emphysema the culprit?Am J Respir Crit Care Med20121852322210781
- CelliBRThomasNEAndersonJAEffect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH studyAm J Respir Crit Care Med200817833233818511702
- LeeJSKimSOSeoJBLongitudinal lung volume changes in patients with chronic obstructive pulmonary diseaseLung201319140541223715996